Conference abstractPublished 6 Nov 2017

Soluble triggering receptor expressed on myelocytes as a biomarker in Lupus. Correlation with SLEDAI

Authors: Ioannis Gkougkourelas, Gkantaras A, Tselios K, Sarantopoulos A, Boura P

Hippokration General Hospital, Greece

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: Soluble Triggering Receptor Expressed on Myelocytes -1 (sTREM-1) is an innate immunity receptor which participates in infectious as well as aseptic inflammatory reactions. Its levels in serum indicate the magnitude of Systemic Inflammatory Reaction Syndrome (SIRS) and can be used to discriminate between infectious and non-infectious causes. Recently, the plasma level of soluble triggering receptor expressed on myeloid cells 1 (sTREM-1) has been proposed as a lupus biomarker, significantly correlated with disease activity. Methods: 16 treatment naive SLE patients (mean age: 32Ã?±11 years, female/male ratio: 15:1) and 17 healthy individuals of the same age were included in the present study. The diagnosis of SLE was based on 2012 Systemic Lupus International Collaborating Clinics (SLICC) classification criteria. All patients were recruited from the clinical immunology outpatient clinic of the 2nd Department of Internal Medicine, Hippokration Hospital of Thessaloniki, over a period of two years. We performed enzyme-linked immune sorbent assay in the serum by the commercially available kit (USCN Life Sciences) following the manufacturer's protocol. Results were expressed as mean +/- sd. Spearman correlation test was used to identify the statistical correlation between sTREM-1 levels in serum and SLEDAI. Results: Median serum sTREM-1 levels were significantly higher in patients with SLE (43.2, range 10.2âÂ?Â?80.1 pg/ml) compared to healthy controls (5 pg/ml; range 3.3-8.3 pg/ml) with p<0.001. When using the Spearman’s rank correlation to study the correlation of s-TREM-1 with SLEDAI, it was found that s-TREM-1 levels positively correlated with activity score (r=0.65 p=0.43). Conclusion: In conclusion, in spite of the enormous number of studies demonstrating lupus biomarkers, reliable biomarkers to predict lupus flare and/or response to treatment have yet to be identified. Larger studies are needed to clarify if sTREM-1 could play a role in determining the activity status of SLE or even herald a flare.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.

Try:

More from this journal

The newest in Journal of Clinical and Cellular Immunology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Cellular Immunology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Ioannis Gkougkourelas”
  • BylineArticles whose byline prints “Gkantaras A”
  • BylineArticles whose byline prints “Tselios K”
  • BylineArticles whose byline prints “Sarantopoulos A”
  • BylineArticles whose byline prints “Boura P”